Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-21 Sale | 2021-09-22 6:08 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,650 | $150.05 | $997,833 | 18,923 (Direct) | View |
| 2021-09-08 Sale | 2021-09-09 5:07 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 1,413 | $130 | $183,690 | 18,923 (Direct) | View |
| 2021-01-05 Sale | 2021-01-06 7:12 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 2,056 | $122.56 | $251,988 | 16,163 (Direct) | View |
| 2020-09-08 Sale | 2020-09-09 5:49 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 2,000 | $89.5 | $179,004 | 19,161 (Direct) | View |
| 2020-04-08 Sale | 2020-04-10 5:30 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,000 | $85.58 | $513,509 | 21,161 (Direct) | View |
| 2020-01-02 Sale | 2020-01-03 9:51 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 1,309 | $51.76 | $67,754 | 14,792 (Direct) | View |
| 2019-09-10 Sale | 2019-09-10 8:25 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 824 | $45.2 | $37,241 | 16,101 (Direct) | View |
| 2019-08-09 Sale | 2019-08-12 4:18 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 3,268 | $45 | $147,060 | 16,925 (Direct) | View |
| 2019-07-16 Sale | 2019-07-17 5:49 pm | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 538 | $40.71 | $21,902 | 20,193 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Option Award | 2024-01-26 4:46 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2023-09-13 8:48 pm | N/A 2033-06-28 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M See Remarks | 0 | $0 | 88,240 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:14 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel | 96,100 | $0 | 96,100 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 4:22 pm | N/A 2032-04-25 | Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel | 177,000 | $0 | 177,000 (Direct) | View |
| 2021-11-19 Disposition | 2021-11-22 09:05 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 65,990 | $0 | 0 (Direct) | View |
| 2021-11-19 Equity Swap | 2021-11-22 09:05 am | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 23,423 | $0 | 0 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-12 4:15 pm | N/A 2024-08-01 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 4,500 | $0 | 23,423 (Direct) | View |
| 2021-11-09 Exercise | 2021-11-12 4:15 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 4,500 | $29.37 | 23,423 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 6:08 pm | N/A 2027-03-02 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,650 | $0 | 18,923 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 6:08 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 5,200 | $30.17 | 18,923 (Direct) | View |
| 2021-09-21 Exercise | 2021-09-22 6:08 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 1,450 | $41.2 | 18,923 (Direct) | View |
| 2021-09-07 Tax Withholding | 2021-09-09 5:07 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 587 | $129.36 | 18,923 (Direct) | View |
| 2021-06-07 Tax Withholding | 2021-06-08 6:53 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 108 | $126.69 | 20,923 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-02 7:50 pm | N/A 2031-01-29 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 23,674 | $0 | 39,837 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 7:12 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 942 | $124.31 | 16,163 (Direct) | View |
| 2020-04-08 Exercise | 2020-04-10 5:30 pm | N/A 2026-03-03 | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,000 | $0 | 21,161 (Direct) | View |
| 2020-04-08 Exercise | 2020-04-10 5:30 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. | 6,000 | $27.97 | 21,161 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 5:33 pm | N/A 2030-01-22 | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 30,703 | $0 | 45,495 (Direct) | View |
| 2019-06-05 Option Award | 2019-06-07 4:39 pm | N/A 2029-06-05 | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 7,800 | $0 | 27,431 (Direct) | View |
Ownership | 2019-06-07 4:38 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | Veness Adam M VP, General Counsel and Sec. | 0 | $0 | 52,931 (Direct) | View |